Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitors of COX-1/COX-2 from Roche

Jan. 22, 1998

Hydroxamic acid-based inhibitors of TNF and/or MMPs under study at Zeneca

Jan. 22, 1998

Innovative Therapies for Rheumatoid Arthritis

Jan. 22, 1998

Preclinical efficacy results reported for Maruho's NSAID

Jan. 20, 1998

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Jan. 19, 1998

Prodrugs of COX-2 inhibitors prepared at Searle

Jan. 15, 1998

Pivotal trial of PROSORBA column in RA stopped early due to favorable results

Jan. 15, 1998

Pharmacia & Upjohn prepares MMP inhibitors

Jan. 13, 1998

Selective COX-2 inhibitors under study at Merck Frosst

Jan. 13, 1998

Effects of neutrophil elastase inhibitor MDL-101146 in two arthritis models

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...